MRK vs WST
By Alex · Tickerpine
Merck & Company, Inc. vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | WST |
|---|---|---|
| Price | $132.92 | $352.29 |
| Market cap | $327.94B | $24.79B |
| P/E ratio | 106.3 | 45.0 |
| ROE | 6.96% | 19.09% |
| Profit margin | 4.77% | 16.98% |
| Revenue growth | 5.10% | 13.80% |
| Dividend yield | 2.56% | 0.25% |
| Beta | 0.21 | 1.14 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs WST in plain English
- MRK is the bigger company — about 13.2× the market cap of WST.
- WST is cheaper on earnings (P/E 45.0 vs 106.3).
- WST earns a higher return on equity (19% vs 7%).
- WST is growing revenue faster (14% vs 5%).
- MRK has the higher dividend yield (2.56% vs 0.25%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Company, Inc. would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.